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Compact Method for Proton Range Verification
Based on Coaxial Prompt Gamma-Ray Monitoring:
a Theoretical Study
F. Hueso-Gonza´lez and T. Bortfeld
Special Issue on Particle Therapy
Abstract—Range uncertainties in proton therapy hamper treat-
ment precision. Prompt gamma-rays were suggested 16 years
ago for real-time range verification, and have already shown
promising results in clinical studies with collimated cameras.
Simultaneously, alternative imaging concepts without collimation
are investigated to reduce the footprint and price of current
prototypes. In this manuscript, a compact range verification
method is presented. It monitors prompt gamma-rays with a
single scintillation detector positioned coaxially to the beam and
behind the patient. Thanks to the solid angle effect, proton range
deviations can be derived from changes in the number of gamma-
rays detected per proton, provided that the number of incident
protons is well known. A theoretical background is formulated
and the requirements for a future proof-of-principle experiment
are identified. The potential benefits and disadvantages of the
method are discussed, and the prospects and potential obstacles
for its use during patient treatments are assessed. The final
milestone is to monitor proton range differences in clinical cases
with a statistical precision of 1 mm, a material cost of 25000
USD and a weight below 10 kg. This technique could facilitate
the widespread application of in vivo range verification in proton
therapy and eventually the improvement of treatment quality.
Index Terms—proton therapy, range verification, prompt
gamma rays, radiation detectors, coaxial, compact.
I. INTRODUCTION
THE number of cancer patients treated worldwide withproton beams has increased from ∼6000 per year in 2007
to ∼20000 per year in 2017 [1]. Paired with the advance in
beam delivery and treatment planning techniques, the number
of hospitals with a proton therapy facility increases annually,
up to ∼80 in 2019. The essential advantage of proton beams
over conventional radiotherapy is their increased ionization
density (Bragg peak) and sharp distal falloff near their maxi-
mum penetration depth [2], [3]. It is estimated that ∼10 % of
all cancer patients, particularly children, could benefit from
proton therapy [4], [5]. However, there is no standardized
or commercial method applied in all proton therapy facilities
to verify in real-time where protons stop within the patient
[6]. This inherent range uncertainty [7] limits to some extent
the potential of protons to conform the dose to the tumor.
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Currently, it forces the application of field patching techniques
and conservative safety margins [8] during treatment planning,
of up to ∼10 mm [9]. A robust treatment plan [10] can ensure
tumor coverage even in the case of proton range deviation,
but at the cost of a higher integral dose to normal surrounding
tissue [11, Fig. 5].
Thanks to the efforts of many research institutions during
the last decades, several solutions towards in vivo range
verification have been proposed and tested [6], [12]. Two
examples thereof are Positron Emission Tomography (PET)
[13] and Prompt Gamma-ray Imaging (PGI) [14]. The first
one has been extensively tested in clinical settings, but is
challenged by the correlation of activity to dose as well as
the metabolic washout effect [12], [15], except in the case of
in-beam PET of short-lived nuclides [16].
The second technique, proposed in 2003 [17], has shown
promising advances in recent years [18]. First clinical tests
were done with a knife-edge slit PGI camera [19], [20], and a
clinical study with a Prompt Gamma-ray Spectroscopy (PGS)
camera [21] is foreseen. Both camera prototypes rely on a
passive collimation of prompt γ-rays (with energies up to
∼6 MeV) and are able to detect the proton range in clinical
conditions with a few millimeters precision.
The higher costs of proton therapy with respect to conven-
tional radiotherapy also limit its applicability [3]. There have
been efforts from research institutions and industrial partners
to reduce the size of proton accelerators [22], [23] as well as
the overall price of facilities [24], [25]. Likewise, there is a
trend in the field of proton range verification to reduce both the
cost and size of currently available prototypes by proposing
innovative detection approaches. Collimated systems like the
PGI and PGS cameras deploy thick tungsten collimators,
that contribute substantially to the overall system weight and
footprint. Indirectly, it also increases the costs due to the
need of an accurate positioning and rotation system sustaining
this weight near the patient. In response to this drawback,
uncollimated range verification systems have been proposed
and are under investigation [26]–[29]. Their smaller footprint
and weight could eventually facilitate the clinical translation.
This article is framed in this context: The need for providing
a range verification system in every treatment room of every
proton therapy facility at an affordable cost. To that extent, the
experience from the current clinical prototypes is essential,
but innovative approaches have to be developed to reduce
their weight, price and complexity, while still addressing the
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required precision and associated technical challenges [30].
The dependency between the number of prompt γ-rays
detected per proton (with uncollimated systems) and the beam
range was observed in [27, Fig. 9] within the context of Prompt
Gamma-ray Timing (PGT), in [31, Fig. 10] using a Compton
camera setup, as well as in Monte Carlo (MC) simulations
[32, Fig. 7]. This information has been incorporated into the
proton range reconstruction algorithm in [33, subsection 3.1.4,
Fig. 3.14]. This methodology was later isolated and named as
Prompt Gamma-ray Peak Integration (PGPI) [28].
The aim of this paper is to propose a compact range
verification method – Coaxial Prompt Gamma-ray Monitoring
(CPGM) – that exploits the aforementioned phenomenon. The
innovation is the positioning of the detector coaxial to the
beam axis and behind the treated area. This enables the
determination of proton range deviations with a single detector
solely based on the number of γ-rays measured and the total
incident protons. The covered solid angle will be maximum
directly in front of the detector and decreases with the inverse
of the square distance (at first order). Consequently, a proton
range overshoot caused by e.g. an unexpected air cavity leads
to an increased number of γ-rays measured per incoming
proton, and vice versa for a range undershoot.
This manuscript is organized as follows. Section II describes
a simple mathematical model and solid angle equations of
coaxial radiation detection, that serves to illustrate the pro-
posed method. In section III, the analytical model is evaluated
for a clinically relevant test case, that could be verified in a fu-
ture proof-of-principle experiment. The implications, benefits
and disadvantages of CPGM in terms of clinical translation
are discussed in section IV, and the main conclusions are
summarized in section V.
II. THEORY
To provide a theoretical framework showing the potential of
the CPGM technique, we investigate a simplified setup with
a homogeneous water phantom and a cylindrical monolithic
detector located downstream and aligned with the proton beam
axis, cf. fig. 1.
z
DetectorWater tank
p
Beam
L
z0
Rw zd
t
2r
Fig. 1. Schematics of the detector setup coaxial to the proton beam incidence
direction z and behind a water target of length L. The phantom entrance is
at position z0, whereas the detector front face is at position zd > z0 + L.
The detector is a monolithic cylindrical crystal of radius r and thickness t.
The proton range within the water tank is Rw < L.
In the following subsections, we formulate an approximate
mathematical model of the γ-ray emission, transmission, solid
angle coverage and γ-ray detection, as well as an estimate of
the radiation background, detector count rates and sensitivity
to range errors in various clinical scenarios. An overview of
the variables and parameters defined throughout this section
is presented in Table I.
A. Emission
We assume an analytical One-Dimensional (1D) model of
the prompt γ-ray emission (including all energies) character-
ized by a flat profile and a sharp distal falloff near the proton
range Rw. This is a coarse approximation of the energy-
integrated depth-emission profile [34, Fig. 6], [35, Fig. 7].
The expression of γ-rays emitted per unit length and incident
proton yields:
dNγ
dz
(z;Rw) ≈ g¯λ · 1
2
(
1 + erf[f¯(Rw − (z − z0))]
)
(1)
for z ∈ (z0, z0 +L), cf. fig. 1. The integral number of emitted
γ-rays can be approximated for f¯−1  Rw by:
Nγ(Rw) =
z0+L∫
z0
dNγ
dz
(z) dz ≈ g¯λRw (2)
The (approximate) value g¯λ ≈ 6 × 10−4 mm−1 is the
energy-integrated prompt γ-ray yield, namely the number of
γ-rays emitted per proton traversing a unit length in water.
f¯ ≈ 0.3 mm−1 is an empirical constant to reproduce the shape
of the distal drop-off of the γ-ray emission at the proton range
Rw. For simplicity, it is considered to be independent from the
initial proton energy. For f¯ →∞, the error function becomes
a step function and the emission profile is a simple rectangular
function [27, Fig. 3].
B. Transmission
The prompt γ-rays emitted towards the detector might be
absorbed, scattered or undergo pair production within the
water phantom. The transmission probability is approximated
as a function of the energy-dependent absorption coefficient
µw(E) [36] and the traversed path. As a first order approxi-
mation, we use a value µ¯w ≈ 10−4 mm−1 that is the sum of
the photoelectric absorption and pair production coefficients
averaged over the energy range of interest. For the setup
described in fig. 1, the transmission probability τ(z) of a ray
emitted at a depth z ∈ (z0, z0 + L) and traveling towards the
detector is given by:
τ(z) = exp
[
−µ¯w
(
L− (z − z0)
)]
(3)
Compton scattering is not included, as high energy γ-rays
are likely to scatter in forward direction [33, Fig. 2.4] and
thus might still impinge the detector. On the other hand,
annihilation photons (following pair production) are less likely
to escape the phantom and reach the detector, due to the
three times higher attenuation coefficient in water compared to
4 MeV photons [36], as well as due to their isotropic emission
distribution; hence their contribution is neglected.
C. Solid angle
The influence of detector position and solid angle covered
with respect to an irradiation source has been comprehensively
studied in [37], [38], and was investigated specifically for the
PGI field by means of MC simulations [32], [39], [40]. Here,
we adopt the analytical solution for an ideal cylindrical detec-
tor of thickness t and radius r, aligned with the beam axis.
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For a γ-ray emitted isotropically at a depth z ∈ (z0, z0 + L),
the relative solid angle Ω/4pi subtended by the front face of
the detector located at position zd yields:
Ω
4pi
(z; zd) =
1
2
1−√ 1
1 + r2/(zd − z)2
 (4)
D. Detection
For a γ-ray crossing the detector, the interaction probability
depends on the crystal thickness t and the energy-dependent
attenuation coefficient µd(E) [36]. In the paraxial approxi-
mation, and using an averaged attenuation coefficient µ¯d, the
interaction probability (including scattering) yields:
η = 1− exp[−µ¯dt] (5)
A fast scintillation crystal like LaBr3 with an average
attenuation coefficient of µ¯d ≈ 2 × 10−2 mm−1 [36] and
a decay time td of 16 ns [41] is chosen as detector. The
monolithic scintillation crystal has a diameter (2r) of 1 ” and
a thickness (t) of 11/2 ”.
The number of prompt γ-rays Nˆd measured by the detector
at a position zd for each incident proton with a range Rw
follows from the multiplication of production dNγ/ dz, trans-
mission τ , solid angle Ω and detection η probabilities, summed
across the target:
Nˆd(Rw, zd) ≈
z0+L∫
z0
dNγ
dz
(z;Rw) ·τ(z) · Ω
4pi
(z; zd) ·η ·dz (6)
For a pencil beam delivering Np protons, the total prompt
γ-ray counts Nd are given by:
Nd = Nˆd ·Np (7)
It is common practice in Pencil Beam Scanning (PBS)
to aggregate data from neighboring spots [20], [21], [42] in
order to achieve around Np ∼ 108 protons per cluster. Since
the lateral spread of the pencil beam close to the proton
range is often larger than the lateral separation between pencil
beams, an improvement in statistical precision can be achieved
without significant loss in lateral resolution.
In the case of accurately characterized phantoms, and well-
known prompt γ-ray yield, detector efficiency and position, the
absolute proton range Rw can be reconstructed by minimizing
the deviation between measured Md and theoretically expected
(eq. 6) prompt γ-ray counts:
argmin
Rw
∣∣∣Md − Nˆd(Rw) ·Np∣∣∣ (8)
E. Radiation background
In addition to the prompt γ-ray signal, a large radiation
background is impinging on the detector. It is induced by
neutron interactions as well as material activation (e.g. positron
emitting isotopes). Due to the time correlation between the
γ-ray signal and the cyclotron Radio Frequency (RF), the
background can be reduced [34], [43], [44], or subtracted
via dedicated algorithms using timing and energy filters [21].
However, even then, the background events are still important
for quantifying the overall detector load. The actual back-
ground is difficult to model and depends on the incident
proton energy, the target composition, as well as the detector
location and other elements in the treatment room. Based on
previous measurements in a clinical scenario [21], [45], [46]
as well as simulations [34, Fig. 6], the average ratio between
overall events and prompt γ-rays can be roughly estimated
with kγ ≈ 2.5 for the current setup in coaxial orientation and
without collimator, cf. fig. 1. It is assumed that an event can
only be detected if it deposits at least 50 keV in the detector.
F. Detector count rate
The beam current in a proton therapy facility is a critical
factor challenging the electronics and affecting the feasibility
of PGI devices [30], [31]. For the widespread Cyclone R© 230
(C230) isochronous cyclotron of IBA (Louvain-la-Neuve, Bel-
gium), the instantaneous proton beam current Ip is approxi-
mately constant at 2 nA [47] at the beam exit window. Cor-
respondingly, the overall detector count rate N˙d,all including
background is:
N˙d,all ≈ kγ · Nˆd · Ip
e
(9)
where e is the elementary charge.
G. Test case
We defined the irradiation of a brain tumor from a horizontal
incidence angle and with the patient couch perpendicular to
the beam axis as benchmark case representative for a clinical
proton treatment. This treatment site is included among the
accepted indications [48], [49] of proton therapy, and the
chosen beam incidence and couch angles are frequent in
clinical treatment plans [50], [51].
To resemble this geometry in our model, cf. fig. 1, we
choose the water tank length L to be equal to the average
human head breadth of 150 mm [52]. The detector is located
at a distance zd = 152 mm from the beam entrance point
z0 = 0 mm.
H. Sensitivity to range errors
The sensitivity of the CPGM method to proton range devia-
tions can be studied analytically by calculating the derivatives
of eq. 6 with respect to parameters of interest. For example,
the relative variation ∆N of the number of detected γ-rays Nˆd
for an error δR in the proton range in water Rw, caused by
an error in the initial proton energy, is given by:
∆N ≡ 1
Nˆd
∂Nˆd
∂Rw
(Rw) · δR (10)
=
δR
Nˆd
z0+L∫
z0
g¯λf¯√
pi
e−f¯
2R2w(z−z0)2τ · Ω
4pi
· η · dz (11)
Intuitively, a deviation δR > 0 of the range Rw (higher
proton energy) results in a higher number of detected counts
due to an increased region of γ-ray production and a larger
subtended solid angle for points closer to the detector. A
2469–7311 c© 2019 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TRPMS.2019.2930362,
IEEE Transactions on Radiation and Plasma Medical Sciences
4 TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES, VOL. X, NO. Y, JULY 2019
third, minor reason is the shorter attenuation path for γ-rays
emitted closer to the detector. To disentangle the two main
contributions, two further partial derivatives are calculated.
For the contribution of the subtended solid angle, we study
the relative count variation ∆Ω for an error δz in the phantom
position z0, while keeping the same proton range and detector
position zd. For symmetry, this analysis is comparable to the
study of an error −δz in the detector position zd with a fixed
phantom position z0:
∆Ω ≡ − 1
Nˆd
∂Nˆd
∂zd
(zd) · δz (12)
=
δzη
2Nˆd
z0+L∫
z0
dNγ
dz
τr2 dz
(zd − z)3 ·
(
1 +
r2
(zd − z)2
)−1.5
(13)
For the second effect, namely the increase in the region of
prompt γ-ray production, we analyze the relative variation ∆γ
in the integral γ-ray emission Nγ , cf. eq. 2, for an error δR
in the proton range Rw:
∆γ ≡ 1
Nγ
∂Nγ
∂Rw
(Rw) · δR (14)
≈ δR
Rw
(15)
A more clinically realistic scenario is studied: the intro-
duction of an air cavity of thickness κ = 2 mm within the
homogeneous water target (length L is unchanged), cf. fig. 1,
with its front face located at a position zκ < z0 + Rw,
where zκ − z0 + κ < L. Neglecting the γ-ray production
in air, the prompt γ-ray detection Nˆd,κ per unit proton in this
heterogeneous geometry is derived from:
Nˆd;κ =
z0+L∫
z0
Ω
4pi
(z; zd) · η · dz·
·

dNγ
dz (z;Rw) · τ(z + κ) , z < zκ
0 , z ∈ [zκ, zκ + κ]
dNγ
dz (z;Rw + κ) · τ(z) , z > zκ + κ
(16)
and the relative difference in counts with respect to the
nominal target follows from:
∆κ = Nˆd;κ/Nˆd;0 − 1 (17)
In any of the presented scenarios, the statistical precision
of the measurement is essential to detect small range errors.
According to Poisson statistics and including partial suppres-
sion of background events based on energy and timing filters
[44], the relative uncertainty ∆s yields:
∆s =
1√
Nd
·
√
1 + (1− χ) · Σt
Tp
· (kγ − 1) (18)
where χ ≈ 0.5 is the fraction of background events that
can be separated from prompt γ-rays based on energy filters,
Σt ≈ 2 ns is the proton bunch time Full Width at Half
Maximum (FWHM) measured for the C230 cyclotron [53],
and Tp = 9.4 ns is the proton bunch period, i.e. the inverse of
the cyclotron RF.
z beam axis coordinate [mm]
z0 front face position of water target 0 mm
zd front face position of the detector 152 mm
L length of the water phantom 150 mm
Rw proton range in water [mm]
r detector radius 1/2”
t detector thickness 11/2”
Nγ γ-rays emitted per incident proton [ ]
g¯λ prompt γ-ray yield per unit length 6·10-4 mm-1
f¯ distal falloff slope 0.3 mm-1
τ transmission probability [ ]
µ¯w average absorption coefficient of water 10-4 mm-1
Ω/4pi relative solid angle subtended [ ]
η probability of interaction in detector [ ]
µ¯d average attenuation coefficient of detector 2·10-2 mm-1
td decay time of the scintillation light pulse 16 ns
Np number of protons within one spot cluster 108
Nˆd prompt γ-rays detected per proton (theory) [ ]
Nd prompt γ-rays detected per spot (theory) [ ]
Md prompt γ-rays measured per spot cluster [ ]
kγ ratio between all counts and the prompt γ-rays 2.5
N˙d,all overall detector count rate [Mcps]
Ip the proton beam (peak) current at the target 2 nA
e elementary charge 1.6·10-19 C
δR absolute error in the proton range Rw 1 mm
δz absolute error in the phantom position z0 1 mm
κ thickness of a cavity within the water target 2 mm
zκ front face position of a cavity within the target [mm]
∆N relative count variation for a range error δR [ ]
∆Ω relative count variation for a target error δz [ ]
∆γ γ-ray emission variation for a range error δR [ ]
∆κ relative count variation due to a cavity κ [ ]
∆s statistical measurement uncertainty [ ]
χ background fraction separated by energy filters 0.5
Σt proton bunch time spread (FWHM) 2 ns
Tp proton bunch period 9.4 ns
TABLE I
VARIABLES AND PARAMETERS USED WITHIN THE THEORETICAL MODEL
OF COAXIAL PROMPT γ-RAY DETECTION, CF. FIG. 1.
I. Validation
The developed analytical model is compared with MC
simulations by means of the TOPAS software [54], version
3.2, which is based on the Geant4 10.05.p01 toolkit [55]. The
proton beam has a lateral spread of 5 mm, no energy or angular
spread, and propagates towards the water phantom. The proton
beam kinetic energy is varied between 1 and 125 MeV in steps
of 1 MeV, and is correlated to the Continuous Slowing Down
Approximation (CSDA) proton range Rw in water via [56].
For every beam energy, Np = 108 histories are generated.
The default physics lists are deployed, and a cutoff of 0.5 mm
is set for all particles.
The water target is a cylinder with 200 mm diameter and
L = 150 mm length. The environment surrounding the target
is set to air. The detector is modeled as a cylinder made of
LaBr3 and is located as described in fig. 1 and table I.
Two different energy deposit scorers (with 1000 bins be-
tween 0 and 10 MeV) are defined in the detector volume. The
first one scores particles (mainly photons) stemming from a
neutron or positron interaction (background), e.g. γ-rays due to
neutron capture on hydrogen; the second one records the rest
(signal), i.e. prompt γ-rays. A detector sensitivity threshold of
50 keV is applied in the posterior analysis. A third scorer is
defined in order to track the total number of prompt γ-rays
emitted across the beam path.
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For a beam energy of 100 MeV, a dedicated phase space
scorer of emitted prompt γ-rays (stemming from proton in-
elastic reactions) is defined, in order to obtain a differential
(energy-integrated) emission profile dNγ/ dz along the z axis,
to be compared against eq. 1.
III. RESULTS
In fig. 2, the overall detector count rate N˙d,all as a function
of the proton range Rw is calculated for the proposed coaxial
detection setup, cf. fig. 1 and table I. As expected, the higher
the incoming proton energy (penetration depth), the larger
the count rate in the detector due to an increased γ-ray
production, solid angle subtended, and decreased attenuation
path. The dashed lines indicate the virtual count rate in case of
a target alignment error of ± 2 mm (across the beam axis). The
red data points correspond to selected proton ranges (beam
energy layers). Their horizontal error bar is set to 0.5 mm
(commissioning tolerance), while the vertical error represents
the predicted statistical uncertainty ∆s × N˙d,all assuming
Np = 108 protons per spot cluster.
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Fig. 2. Modeled γ-ray count rate N˙d,all as a function of proton range Rw,
cf. eqs. 6 and 9, of a 1”×11/2” LaBr3 detector located on the beam axis
behind a 150 mm long water phantom, as described in fig. 1 and table I.
The proton beam current at the target is Ip = 2 nA and the number of
protons per spot cluster is Np = 108. The solid line refers to the nominal
situation, whereas the dashed lines correspond to the results expected for a
virtual target misalignment of ± 2 mm (along the beam axis). The red points
are selected proton ranges accompanied with 0.5 mm horizontal error bars, and
with vertical error bars that represent the statistical uncertainty ∆s × N˙d,all
according to the collected prompt γ-ray counts per spot, cf. eqs. 7 and 18.
The relative variation of the solid curve in fig. 2 is depicted
in fig. 3 as a function of proton range Rw, cf. eq. 11. In
this case, the statistical uncertainty ∆s is superimposed as a
dashed line, and imposes a theoretical precision limit for a
spot cluster with Np = 108 protons. The concave shape of the
solid curve is mainly due to the interplay of two effects: the
slower (relative) rise in γ-ray production with proton range for
deeper irradiation points and the faster increase of the solid
angle subtended by the detector.
Both contributions are isolated in figs. 4 and 5, respectively,
by calculating the partial derivatives of eqs. 15 and 13. The
combination of both effects leads to the shape visible in
fig. 3. It should be noted that, in the case of fig. 5, a
target misalignment of 1 mm would not be measurable for a
proton range below 60 mm. The reason is that the statistical
measurement uncertainty, considering 108 delivered protons,
is larger than the expected change in the prompt γ-ray signal.
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Fig. 3. Solid line: Relative change ∆N of measured γ-rays as a function of
proton range Rw for an error δR = 1 mm, cf. eq. 11, for the coaxial detection
setup described in fig. 1 and table I. Dashed line: Statistical measurement
precision ∆s, cf. eq. 18, for a spot cluster with Np = 108 protons.
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Fig. 4. Solid line: Relative change ∆γ of emitted γ-rays as a function of
proton range Rw for an error δR = 1 mm, cf. eq. 15. Dashed line: Statistical
measurement precision ∆s, cf. eq. 18, for the coaxial detection setup described
in fig. 1 and table I, and for a spot cluster with Np = 108 protons.
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Fig. 5. Solid line: Relative change ∆Ω of measured γ-rays as a function of
proton range Rw for an error δz = 1 mm in phantom position, cf. eq. 13,
for the coaxial detection setup described in fig. 1 and table I. Dashed line:
Statistical measurement precision ∆s, cf. eq. 18, for a spot cluster with Np =
108 protons.
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The variation in detected counts ∆κ due to the introduction
of an air cavity (thickness κ = 2 mm) in beam direction with
respect to the homogeneous scenario is presented in fig. 6. The
dashed black curve represents the boundary above which the
expected count variation ∆κ is below the statistical measure-
ment precision ∆s at that abscissa Rw. For the majority of
proton ranges Rw and cavity positions zκ, the expected count
change is higher than the statistical measurement uncertainty
for Np = 108 delivered protons.
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Fig. 6. Relative change ∆κ of measured γ-rays after introduction of a 2 mm
cavity in the beam path, as a function of original proton range Rw and cavity
position zκ, cf. eq. 17, for the coaxial detection setup described in fig. 1 and
table I. The black dashed line represents the statistical measurement precision
∆s, cf. eq. 18, for a spot cluster with Np = 108 protons.
In fig. 7, the number of prompt γ-rays emitted per proton
as obtained with a TOPAS MC simulation (black dots) is
depicted and compared with the proportional estimation g¯λRw
of the analytical model (red solid line), cf. eq. 2. The model
shape, with a fixed parameter g¯λ = 6× 10−4, is a rough first-
order approximation of the simulated depth-emission profile
obtained. The model underestimates the slope of the curve by
30 % for small proton ranges and overestimates it by 30 % at
larger proton ranges.
The choice of a constant value g¯λ implies that the predicted
prompt γ-ray emission distribution is flat, except for the
smooth falloff near the particle range according to parameter
f¯ , cf. eq. 1. For an incident proton energy of 100 MeV, this
approximation (solid red line) is compared with a TOPAS
MC simulation (black dots) of the differential prompt γ-
ray production, cf. fig. 8. The modeled profile overestimates
the emission about 20 % from the TOPAS simulation and
underestimates it by 30 % close to the proton range Rw
(vertical purple line).
The ratio between all events detected and the subset of those
that are prompt γ-rays is shown in fig. 9, where the TOPAS
MC simulation (black dots) is compared with the constant
estimate kγ = 2.5 of the analytical model (solid red line), cf.
subsection II-E. The model overestimates the amount (ratio)
of background for all proton ranges; the smaller the proton
range, the higher the deviation with respect to the simulation.
A similar trend is observed in fig. 10, where the detector count
rates due to background (green) and prompt γ-rays (blue) are
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Fig. 7. Total number of prompt γ-rays Nγ (all energies) emitted per proton as
a function of the beam range Rw in the water phantom described in fig. 1 and
table I. The corresponding beam energy is indicated in the upper horizontal
axis. The points with error bars represent the results obtained with a TOPAS
simulation and Np = 108 histories, while the solid red line indicates the
analytical model prediction, cf. eq. 2 and table I.
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Fig. 8. Number of prompt γ-rays Nγ (all energies) emitted per proton and
unit length as a function of the penetration depth z − z0 within the water
phantom described in fig. 1 and table I. The incident beam energy is 100 MeV,
corresponding to a proton range in water of Rw = 76.4 mm (vertical purple
line). The points with error bars represent the results obtained with a TOPAS
simulation and Np = 108 histories, while the solid red line indicates the
analytical model prediction, cf. eq. 1 and table I.
shown for both the MC simulation and the analytical model,
cf. eq. 9.
IV. DISCUSSION
The proposed method for range verification in proton ther-
apy exploits the strong dependency of the integral number
of measured γ-rays on proton range. The key innovation
of the CPGM approach with respect to PGPI [28] is the
coaxial detector orientation and the positioning behind the
treated area. This is a convenient geometry to maximize the
detection efficiency for γ-rays produced near the Bragg peak.
If the number of incident protons, the prompt γ-ray yield, the
phantom material and the detector response are well known,
the proton range can be inferred by solely counting the number
of prompt γ-rays detected within a broad energy window.
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to prompt γ-rays for the coaxial detection setup described in fig. 1 and
table I. The points with error bars represent the results obtained with a TOPAS
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A. Limitations
The formulated 1D model, cf. section II, aims at a sim-
plified analytical description of the prompt γ-ray emission
and detection based on rough estimates, in order to assess the
feasibility of the CPGM method. A number of approximations
and limitations are identified:
• Three-Dimensional (3D) information is not taken into
account, e.g. the lateral spread of the proton pencil beam
as a function of penetration depth.
• The energy spread of the incident proton beam is not
modeled.
• A simplified γ-ray emission profile is assumed with a
shape independent of proton energy, cf. eq. 1, and an
approximate γ-ray yield is used.
• Characteristic γ-ray lines and Doppler broadening are not
considered.
• γ-ray anisotropy effects are not incorporated [57], [58,
Fig. 3], [59, Fig. 2], [60].
• An ideal homogeneous water phantom is chosen as target.
• The effect of Computed Tomography (CT) imaging un-
certainties on attenuation coefficients and stopping power
conversion are not modeled.
• The dependency of attenuation coefficients on γ-ray
energy is not taken into account.
• Scattering of prompt γ-rays before reaching the detector
is neglected, which is however significant at low γ-
ray energies (less forward-peaked) and large distances
between scattering point and detector.
• Detection of prompt annihilation photons, stemming from
prompt γ-rays that undergo pair production in the phan-
tom, is not considered.
• A simple model of the radiation background is adopted.
• Neutron interactions and activation in the detector [61],
[62] are not included.
• The detector response (γ-ray energy deposit) is not in-
cluded, and the paraxial approximation is used.
• Second-order corrections needed for PBS, as spots are
not coaxial (in general) with the room isocenter (detector
axis), are not incorporated.
• A potential systematic error in the incident number of
protons is not accounted for.
• The statistical error in the stochastic process of γ-ray
transmission is not considered.
• Bias due to systematic errors in the background subtrac-
tion is not investigated.
• Sensitivity to range errors is studied only for simplified
cases: global beam range errors (proton energy), target
shifts (across beam direction) and local 2 mm air cavities.
B. Sensitivity to range errors
The sensitivity to range errors is studied for a representative
brain tumor irradiation from a horizontal beam angle. With a
single 1”×11/2” scintillation detector, changes of over 3 % in
the prompt γ-ray count are expected for an absolute proton
range error of δR = 1 mm, cf. fig. 3. In the case of 108
delivered protons, the statistical measurement precision would
be enough to detect that variation with significance (1σ).
On the other hand, the proposed setup would only be able
to detect a target misalignment across the beam axis of δz =
1 mm for proton ranges larger than 6 cm, cf. fig. 5. For smaller
proton ranges, the sensitivity would be rather 2 mm, (unless
a larger spot cluster or a bigger detector were deployed). A
2 mm precision would be still an improvement compared with
the safety margins currently applied [9], [51].
A potential improvement might be the use of a second
detector in an upstream orientation and slightly off beam axis,
close to the beam entrance point, so that the maximum covered
solid angle is in the region where the downstream detector is
less sensitive. By combining information from both detectors,
complementary information about the absolute target position
could be deduced.
The effect of anatomy changes in the patient with respect to
the planning CT scan [63] is investigated by adding air cavities
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of κ = 2 mm thickness within the beam path, cf. fig. 6. If
the cavity is located close to the end of range, the statistical
measurement precision is not enough to detect this effect, in
part because most of the dose has already been deposited
in the expected region. For large proton ranges and cavity
locations in the beginning of or amid the beam path, count
rate variations of 4 % are expected, which are higher than the
statistical uncertainty for spots with 108 protons.
In the clinical context, where extended targets are irradiated
with PBS, the detector is kept fixed at the beam isocenter. This
implies that the scanned pencil beam is no longer coaxial to the
detector, which reduces the sensitivity of the CPGM method
to range errors. The geometrical distance between emission
point and detector front face is instead
√
(zd − z)2 + ∆x2 =
(zd−z)/ cosα, where ∆x is the lateral separation with respect
to the beam axis and α is the angle between the z axis
and the source-to-detector axis. Hence, at first order in the
asymptotic series expansion of eq. 4, the count rate variation
∆Ω due to the solid angle effect is corrected by a factor
cos3 α = [1 + ∆x2/(zd − z)2]−1.5 within the integrand, cf.
eq. 13. For example, at a proton range Rw = 100 mm and a
lateral separation ∆x = 50 mm, the angle α ranges between
10 and 40 degrees across the beam track. Compared to the
coaxial case, ∆Ω decreases from 2.5 %/mm to 1.4 %/mm,
still above the statistical precision of 0.8 %, cf. fig. 5.
In practice, whether the CPGM method is able to measure
1 mm range shifts with statistical significance depends on the
lateral distance of the pencil beam to the isocenter, and on the
number of protons within the spot cluster. A comparable kind
of inhomogeneous precision depending on the considered spot
is also present in other PGI systems oriented perpendicularly
to the beam: For spots with the same range and number of
protons, but laterally further away from the camera, the solid
angle and transmission probability are smaller, so that the
number of collected counts (and thus the statistical precision)
decreases.
C. Validation
The incorporation of all effects mentioned in subsec-
tion IV-A exceeds the scope of this paper and should be
subject of either more sophisticated analytical algorithms [64]
or a full MC simulation. It should take into account realis-
tic patient geometries, incorporate treatment room elements
to reliably simulate neutron-induced background, as well as
model accurately the scintillation detector. Consequently, the
results presented are a qualitative measure and indicate the
potential of the underlying methodology. To assess whether
the limitations of the analytical model could invalidate the
measurement principle, a TOPAS MC simulation is conducted
with a simplified geometry, cf. subsection II-I, mimicking the
water target of fig. 1.
The results are compared with the model in view of the most
critical approximations and estimates included in the model. If
these were off by more than a factor of two, it could jeopardize
the feasibility of the CPGM method. Specifically, the linear
approximation in the prompt γ-ray production is tested in
fig. 7, the flat profile g¯λ is studied in fig. 8, the constant ratio
kγ between all events and prompt γ-rays is presented in fig. 9,
and the overall detector count rates are shown in fig. 10.
The fact that the model overestimates the slope in the
prompt γ-ray production by 30 % at large proton ranges
implies a noticeable reduction of the expected count variation
∆γ . However, this is a minor effect at large proton ranges
compared to the solid angle contribution ∆Ω in case of a
global range error, cf. fig. 4. On the other hand, the assumption
of a constant ratio kγ = 2.5 is conservative compared to the
results obtained with a TOPAS MC simulation. For all proton
ranges, the amount of background obtained with TOPAS
MC is smaller than predicted. Correspondingly, the modeled
detector count rates for prompt γ-rays and background are
discrepant with the simulated ones, with maximum deviations
of ∼0.5 Mcps.
These differences highlight the limitations of the analytical
model, but also demonstrate its ability to provide reasonable
estimates with coarse approximations in the correct order of
magnitude. Being aware that the analytical model is just a
simple provisional means and not a goal, and that the MC
simulations used as reference might also suffer from large
uncertainties [65], [66], this theoretical evaluation aims at
illustrating the fundamental principles and potential feasibility
of a new range verification strategy. It does not provide a
precise validation or proof-of-principle of CPGM, but rather
encourages its future verification with experimental measure-
ments in a proton therapy facility, and the development of a
MC-based (instead of analytical) detection model, as in [21].
D. Absolute range prediction
Our analysis only investigates the sensitivity to range de-
viations with respect to a nominal well-known situation. A
more difficult requirement would be the prediction of the
absolute proton range for the first treatment fraction. In that
case, the absolute calibration of the ionization chamber mea-
suring the number of incoming protons Np is very important
[67]. Furthermore, the absolute accuracy of the prompt γ-ray
production cross sections would be a critical factor (unless
a second detector is added in an upstream location, which
can partially rule out a systematic error). Currently, there are
deviations between measured and reference cross sections of
∼20% [21]. Hence, an absolute range verification with CPGM
is not realistic in the short to medium term. Extra efforts should
be undertaken by a task group within the scientific community,
in order to improve the precision down to 2 % and to agree
on double-differential nuclear reaction cross sections [68] in
consensus [69].
Furthermore, as the cross sections are target-specific, a pre-
cise estimate of the nuclear composition of the irradiated tissue
is needed, or it has to be obtained from the ratios between
different γ-ray lines [70] and an underlying MC simulation
framework [21]. In this context, it would be also advisable
to validate PGI devices within a standardized experiment
framework and ground-truth anthropomorphic phantoms [71].
Finally, for the particular case of CPGM, the knowledge
about the patient composition behind the irradiated area is
also important, as the attenuation of γ-rays until reaching the
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coaxial detector also affects the number of γ-rays measured.
This problem will be less critical when dual-energy CT [72]
becomes more commonplace in proton therapy facilities [73],
thereby increasing the precision in the characterization of γ-
ray attenuation coefficients [74] and elemental concentrations.
E. Detector count rate
The choice of LaBr3 as scintillation material is motivated
by its excellent energy resolution and short decay time of
16 ns. The first trait is convenient for the compensation of gain
fluctations in the Photomultiplier Tube (PMT) as a function of
count rate [75]. The second is extremely important in order
to minimize the pile-up probability. The expected count rate
(including background) for the proposed setup reaches several
Mcps, cf. fig. 2. This detector load is quite challenging [30],
but as only one detector with individual readout is deployed, it
can be addressed with sophisticated pile-up fitting algorithms,
as shown by [76], [77], and state-of-the-art single-channel
digitizers.
F. Radiation background
The presence of neutron-induced background is a critical
factor that might affect the precision of the method. A propor-
tional ratio kγ has been adopted in this study, but experimental
measurements are needed to develop a more realistic model
depending on the incident proton energy, as well as to verify
the absolute yield. Additionally, the increase in neutron fluence
in forward direction [39] has to be incorporated in the model.
The downstream position of the CPGM detector is a double-
edged sword: it maximizes the sensitivity to prompt γ-rays
near the Bragg peak, but at the price of an increase in neutron-
induced background.
A large radiation background is inconvenient for the CPGM
technique due to two reasons. First, it leads to a very high
detector count rate, especially at high initial proton energies,
that challenges the electronics design. Second, it might bias
the estimate of the integral number of prompt γ-rays, as
the subtraction of neutron-induced background based on tim-
ing measurements [34] is accomplished experimentally with
semi-empirical algorithms [21]. Ideally, the neutron-induced
background should be fully modeled and incorporated as a
measurement value [78] in addition to prompt γ-rays, as it
carries residual information about the proton range, cf. fig. 10.
However, the neutron interaction processes are complicated to
model and strongly depend on the surrounding materials in
the treatment room, which are not well characterized.
G. Integration in treatment room
In general, range verification techniques comprise several
detection units [16], [28], [29], [79]. Some prototypes deploy
a thick collimator and a heavy supporting frame [21, Fig. 10],
[80, Fig. 4], which poses an engineering challenge in case
of an integration with the rotating gantry to match any beam
angle. In contrast, the CPGM is a minimalistic approach using
a single detection unit and no collimator. A model of a gantry
treatment room with the CPGM detector setup attached to the
Nozzle
DetectorPatient
Couch
Arm
X-ray panel
X-ray panel
Fig. 11. 3D model of the proposed detection setup in a proton treatment room.
The beam incidence angle is horizontal and the irradiated area is the patient’s
intracranial region. The scintillation detector (red) is behind the treated area
and coaxial to the beam, and is mounted on a rotating arm (green) that is
attached to the patient couch. The orthogonal X-ray panels (top and right)
can be used for measuring the detector position relative to the patient without
interfering the treatment. The number of γ-ray detections per unit proton is
correlated to the beam range. Note that the chosen geometry is compatible
with the frequent brain treatment scenario with no couch rotation [50].
patient couch is illustrated in fig. 11. The estimated detector
weight is below 500 g, and the weight of an articulating arm is
below 9 kg. Due to the compactness of the proposed system, its
integration seems less complex and more affordable than for
other PGI methods, and is especially promising for treatment
rooms with space constraints [24].
H. System alignment
One important aspect of range verification devices based on
PGI is the system alignment with respect to the room isocenter,
e.g. with embedded lasers [21]. The positioning uncertainty
along the beam direction and the alignment reproducibility are
critical, and can be the main limiting factor for the achievable
range precision [20]. Moreover, the heavier the system, the
more efforts are needed to achieve the required precision, even
more if the γ-ray camera rotates to match the beam incidence
angle.
For the CPGM approach, we can benefit from the small
footprint of the detector as well as its position close to the
patient. The in-room orthogonal radiographies used for patient
positioning in the clinical workflow are very convenient for
detector positioning, as the setup does not collide with the two
extended X-ray panels, cf. fig. 11. It is also not mandatory
to place the detector at the exact same position for every
treatment fraction. It is rather necessary to know accurately
its position with respect to the patient. The two orthogonal
X-ray images can offer a sub-millimeter resolution [81] of the
3D detector position, that can be directly mapped to the beam
coordinate system.
I. Compatibility and applicability
Range verification devices based on PGI are usually de-
signed for a specific type of proton accelerator used at the
developing institution. Consequently, the results cannot be
directly translated to other types of accelerators, since the
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expected beam current and beam time structure [30], [53],
[82] might be drastically different. In the case of CPGM,
we focus on the most widespread accelerator type [83], and
the conclusions drawn in this study might potentially not be
extrapolated to facilities with a different machine type.
Concerning the versatility of PGI devices, due to their
footprint, a single design cannot be applied in general for
every treatment site and every possible patient couch angle so
far. Thus, it is convenient to focus first on the most common
treatment sites, as well as those who would benefit most of
an in vivo range verification. In this study, we choose the
treatment of brain tumors from a horizontal incidence angle,
and no patient couch rotation, as it is common in clinical
practice [50]. It should be noted that the study is extensible
to other beam incidence angles, as the detector can rotate
accordingly around the head, cf. fig. 11.
In general terms, the precision of the method increases the
closer the detector is to the Bragg peak. Thus, women could
potentially benefit more than men from the CPGM technique
due to their smaller average head breadth [52]. This would
be also the case for pediatric tumors. The extensibility of this
approach to other treatment sites depends on the particular
beam incidence and patient couch angle. In the case of a
prostate treatment from a horizontal beam angle, the coaxial
detector position downstream would be far away from the
Bragg peak. The range measurement could be done with ease,
but the achievable precision would diminish. One alternative
could be to move the detector slightly off the beam axis, so
that it can reach a closer position to the Bragg peak from
above the patient.
J. Price estimate
The literature about the cost of PGI prototypes is scarce due
to early stage of research development and the several years
remaining until a final product is actually commercialized.
Some rough estimates state an overall material cost of at
least 200 k$ [29] and up to 1 M$ [84], not accounting for
development, commissioning and maintenance. Furthermore,
these costs do not include the potential integration in the
rotating gantry structure, for covering several beam incidence
angles.
The cost-effectiveness of range verification devices is im-
portant taking into account its potential applicability in every
treatment room of every proton center. Being an optional
quality assurance device, not essential for the treatment, the
benefits provided by improving the delivery precision should
not be burdened by a prohibitive cost in addition to the already
expensive proton facility [85], [86]. While there is consensus
that PGI devices are able to provide useful information for
proton range determination, it is still questionable whether
they will manage to offer it at an affordable price, especially
in the case of Compton cameras [31]. There is a trend towards
simpler range verification solutions [26]–[28] that do not
ensure an accuracy as high as already existing prototypes [21],
[42], but that might have an easier translation to all clinics due
to their lower cost [87].
In the case of the CPGM technique, designed for minimum
expense and impact on the treatment room, while keeping an
Item Amount / $
DETECTOR1”×11/2” scintillation crystal 6,0001” fast PMT 1,000
(7,000)
ELECTRONICS
Voltage divider and High Voltage (HV) supply 1,000
Fast amplifier 1,000
Power supply and circuit board 1,000
(3,000)
DATA ACQUISITION
Fast single-channel digitizer 5,000
High-end computer 7,000
(12,000)
MECHANICS
Articulating arm 2,000
Detector mount 1,000
(3,000)
TOTAL MATERIAL COST 25,000
TABLE II
ROUGH ESTIMATE OF THE MATERIAL COSTS (BUDGETARY PRICE AS OF
2019) OF A CPGM DEVICE FOR PROTON RANGE VERIFICATION IN A
CLINICAL TREATMENT ROOM.
acceptable range precision, we provide a budget estimate in
table II based on quotations from year 2019. The total material
cost is expected to be about 25 k$.
K. Overview
Table III summarizes the Strengths, Weaknesses, Opportu-
nities and Threats (SWOT) of the CPGM method described
throughout the manuscript. The simplicity of the design using
a single detector is one big advantage. Its small footprint and
low weight allow for a seamless integration with the couch
of the treatment room for any incidence angle. If a proof-of-
principle experiment validates the CPGM method, it would
become an ideal candidate for in vivo range verification in
compact proton treatment rooms. At the same time, it does
not interfere with the embedded X-ray panels. They could
be used for accurate detector positioning, and no additional
laser alignment system is needed. Furthermore, the method
does not directly depend on the bunch time structure, one of
the challenges faced in the PGT technique [53]. Altogether,
this minimalist setup might enable range verification at an
affordable price of 25 k$.
A disadvantage of the CPGM method is the dependence
on the incident number of protons, which is given by the
ionization chamber within the beamline. The chamber has to
be calibrated very accurately and compensated for pressure or
temperature variations. Likewise, the detector response needs
to be precisely characterized, and the scintillation crystal aging
has to be monitored. Temperature effects on the light yield and
PMT gain should be corrected with stabilization techniques
[88]. Furthermore, a good knowledge of the γ-ray attenuation
coefficients in the patient volume behind the treated area is
mandatory. The correct estimation of the nuclear concentration
within the irradiated area is also essential. Aside from that,
another disadvantage is that the distance across the beam axis
between detector and treated volume should be as small as
possible. Hence, not all treatment sites or patients may benefit
from this technique with the same precision. Women and
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especially children might be more indicated than adult men
(on average) for a precise range verification with CPGM.
Other difficulty faced by the CPGM technique is the chal-
lenging high count rates in the detector, in part due to the in-
creased neutron-induced background in downstream positions.
The radiation background has been roughly estimated but
has to be verified experimentally. Also, the CPGM technique
depends on nuclear reaction cross section data, which currently
suffer from large uncertainties. Aside from that, a potential
future obstacle (for any PGI device) is the increase of the
instantaneous beam current in the new accelerators like the
synchrocyclotron S2C2 from IBA [82], that leads to much
higher detector count rates. This would force a challenging
research towards the use of faster scintillation materials, e.g.
BaF2, PbWO4, PrBr3 [41] or plastic, than the one deployed in
this study, at the price of a worse energy resolution.
Given the aforementioned disadvantages and potential
obstacles, there is room for improvement and possible
workarounds. One promising way is the addition of a second
detector in an upstream position. Both detectors would be
sensitive to complementary regions of the patient, which could
potentially mitigate errors due to the uncertainty of the nuclear
reaction cross sections and even cancel the dependency on
the incoming number of protons. A shift of the downstream
detector to slightly off-axis angles might also reduce the
neutron-induced background, while still keeping a strong
dependency of registered γ-rays with penetration depth. Fur-
thermore, information obtained by CPGM could be combined
with that derived from PGS or PGT techniques, but using the
same single detector (and no collimator). These can provide
additional information to reduce the error in the assumed
nuclear concentrations and absolute proton range. Moreover,
there might be the possibility to measure the integral number
of annihilation photons during beam pauses, as with in-beam
PET [16]. This could also provide further insights about
absolute proton ranges in patients. Of course, a compromise
has to be found between the additional information gained by
integrating further methods within CPGM, and the complexity
and price that it might add to the method. A simple and
robust method with an acceptable accuracy could potentially
have more opportunities to become a widespread application
in clinic routine.
V. CONCLUSIONS
A method for range verification in proton therapy based
on the acquisition of coaxial prompt γ-rays is presented,
which is referred to as Coaxial Prompt Gamma-ray Monitoring
(CPGM). In contrast to other PGI prototypes comprising
several detection units located perpendicularly or upstream of
the beam axis, we propose a single γ-ray detector without
collimation positioned coaxially to the proton beam incidence
direction. In this particular geometry, and assuming ideal
homogeneous phantoms and well-known detector response,
the integral number of prompt γ-rays measured encodes the
proton range.
Based on a simplified theoretical model of prompt γ-ray
emission and detection, the sensitivity of CPGM to virtual
Strengths Weaknesses
Single detector, no collimator
Compactness
Lightweight
Integration with gantry
Alignment with X-ray panels
Independent of bunch structure
Affordable
Dependence on proton number
Efficiency calibration
Attenuation coefficients
Nuclear concentration
Shallow treatment sites
Extension to two detectors
Slightly off-axis
Dual-energy CT
Integration with PGT
Integration with PGS
Combination with PET
Widespread applicability
Challenging count rate
Neutron-induced background
Nuclear cross sections
New accelerators
Opportunities Threats
TABLE III
ANALYSIS OF STRENGTHS, WEAKNESSES, OPPORTUNITIES AND THREATS
(SWOT) OF THE CPGM METHOD.
range deviations is estimated. For a single 1”×11/2” LaBr3
scintillation detector positioned behind a 150 mm water target,
we predict a change of more than 3 % in the measured number
of γ-rays for a global range error of 1 mm. Assuming a spot
cluster with 108 protons, the measurement precision would be
enough to detect such a variation with a 1σ significance. This
compact method could be easily applied in the clinics and
would have a seamless integration within the gantry treatment
room.
Our theoretical investigation is the first step towards an ex-
perimental proof-of-principle study in a proton therapy facility.
This experiment has to discern whether the approximations
assumed in the model are legitimate and the proposed method
can be realistically applied in a clinical scenario. Especially,
the predicted neutron-induced background in forward direction
and the ability of the detector to cope with very high count
rates have to be confirmed. Furthermore, the prompt γ-ray
yields and detector response have to be characterized and
calibrated with a very high precision.
Ultimately, the CPGM method could enable proton range
verification at a more affordable price than other PGI pro-
totypes with heavy collimators and multiple detectors, while
keeping an acceptable accuracy. Specifically, we aim at mon-
itoring the proton range deviations with a precision of σ =
1 mm for a spot cluster of 108 protons, at a clinical beam
current of 2 nA, setup costs of 25 k$ and a weight below 10 kg.
The eventual achievement of this milestone could facilitate a
widespread application of in vivo range verification in proton
therapy facilities, in order to improve the quality of patient
treatment.
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